Terrance Snutch

Dr Terrance Snutch completed his PhD in molecular genetics at Simon Fraser University and then work as a post-doctoral fellow at CalTech. He joined UBC about three decades ago and is based at the Michael Smith Laboratories. He is Canada Research Chair in  Biotechnology and Genomics-Neurobiology and Director, Translational Neuroscience, Djavad Mowafaghian Centre for Brain Health. The Snutch Lab employs state-of-the-art 3rd generation sequencing (MinION) aimed at defining genetic and epigenetic disease-related states, with emphasis on the discovery of new drugs for epilepsy and chronic pain.

The Snutch Lab research facilities are located in the Michael Smith Laboratories and the Djavad Mowafaghian Centre for Brain Health, on the campus of The University of British Columbia in beautiful Vancouver, BC, Canada.

Under the direction of Professor Terrance P. Snutch, the lab’s major research interest is the study of the molecular mechanisms of signal transduction in the nervous system and its relationship to neurological disorders. The research utilizes a multidisciplinary approach to characterize various aspects of the molecular, electrophysiological, pharmacological, biochemical and genetic properties of ion channels in normal and pathophysiological states.

Current projects involve epilepsy, migraine, schizophrenia, autism and chronic pain. The lab also employs state-of-the-art 3rd generation sequencing (MinION) aimed at defining genetic and epigenetic disease-related states. Prof. Snutch actively translates discoveries to industry and patients and to date, has designed and advanced new drugs for pain and epilepsy into the clinic.

Peer-reviewed publications

2021 Faculty of Medicine Bill and Marilyn Webber Lifetime Achievement Award

LinkedIn